News Posts List
GREENS SLASH CANCER RISK
10/06/2012
A study highlights the link between poor diet and the killer disease and confirms that certain vegetables have the power to heal the bodyâs cells.
Pfizerâs patent on cancer drug revoked
10/06/2012
In yet another blow to Big Pharma, the Delhi Patent Office has revoked a patent granted in 2007 to US drugmaker Pfizer for sunitinib (brand name Sutent), a drug used to treat a type of kidney cancer, which had global sales of $1.19 billion in 2011.
AVEO seeks FDA approval for kidney cancer drug
10/06/2012
The Cambridge company and Japanese drug developer Astellas Pharma Inc. today announced that AVEO has submitted a new drug application to the U.S. Food and Drug Administration seeking approval for tivozanib.
Stress, depression may affect cancer survival
10/04/2012
Several recent studies underscore how critically important it is for those fighting illness to learn how to combat stress.
Renal Cell Carcinoma Phase III Data
10/04/2012
New trial results on pazopanib and temsirolimus have important implications for patients.
When the NHS refused life-saving drugs to countless cancer patients, there was one woman who wouldn't take no for an answer
10/03/2012
When youâre told âYou have cancerâ, it can seem the most shattering news you could possibly receive. But many patients are then told something infinitely worse: âThere is a treatment â but we canât afford to give it to you.
Pazopanib Passes Kidney Cancer Test
10/03/2012
After independent data review, patients on pazopanib achieved a median progression-free survival of 8.4 months compared with 9.5 months for patients on sunitinib â a nonsignificant difference that fell within the prespecified statistical bounds for achieving non-inferiority, according to Robert Motzer, MD, of Memorial Sloan-Kettering Cancer Center in New York City.
Phase III Data in Treatment of Renal Cell Carcinoma Reported
10/02/2012
New results released at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna may have important implications for patients.
Vaccine for Kidney Cancer Shows Activity
10/02/2012
The first renal cell carcinoma (RCC) patients have been treated with an RCC-specific therapeutic vaccine in early-stage clinical trials.
News Feed